The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study
- PMID: 32654390
- PMCID: PMC7669676
- DOI: 10.1111/liv.14600
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study
Abstract
Background & aims: Non-alcoholic fatty liver disease confers increased risk for cardiovascular disease, including heart failure (HF), for reasons that remain unclear. Possible pathways could involve an association of liver fat with cardiac structural or functional abnormalities even after accounting for body size.
Methods: We analysed N = 2356 Framingham Heart Study participants (age 52 ± 12 years, 52% women) who underwent echocardiography and standardized computed tomography measures of liver fat.
Results: In cross-sectional multivariable regression models adjusted for age, gender, cohort and cardiovascular risk factors, liver fat was positively associated with left ventricular (LV) mass (β = 1.45; 95% confidence interval (CI): 0.01, 2.88), LV wall thickness (β = 0.01; 95% CI: 0.00, 0.02), mass volume ratio (β = 0.02; 95% CI 0.01, 0.03), mitral peak velocity (E) (β = 0.83; 95% CI 0.31, 1.36) and LV filling pressure (E/e' ratio) (β = 0.16; 95% CI 0.09, 0.23); and inversely associated with global systolic longitudinal strain (β = 0.20, 95% CI 0.07, 0.33), diastolic annular velocity (e') (β = -0.12; 95% CI - 0.22, -0.03), and E/A ratio (β = -0.01; 95% CI - 0.02, -0.00). After additional adjustment for body mass index (BMI), statistical significance was attenuated for all associations except for that of greater liver fat with increased LV filling pressure, a possible precursor to HF (β = 0.11; 95% CI 0.03, 0.18).
Conclusion: Increased liver fat was associated with multiple subclinical cardiac dysfunction measures, with most of associations mediated by obesity. Interestingly, the association of liver fat and LV filling pressure was only partially mediated by BMI, suggesting a possible direct effect of liver fat on LV filling pressure. Further confirmatory studies are needed.
Keywords: heart failure; non-alcoholic fatty liver disease; subclinical cardiovascular disease.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures
References
-
- Kenchaiah S, Evans JC, Levy D, et al. Obesity and the Risk of Heart Failure. N Engl J Med. 2002;347:305–313. - PubMed
-
- Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol &Amp; Hepatol. 2013;10:686. - PubMed
-
- Younossi Zobair M, Koenig Aaron B, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015;64:73–84. - PubMed
Publication types
MeSH terms
Grants and funding
- L30 DK106778/DK/NIDDK NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- UH2 TR000921/TR/NCATS NIH HHS/United States
- R01 HL077477/HL/NHLBI NIH HHS/United States
- R01 AG047645/AG/NIA NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- R01 HL143227/HL/NHLBI NIH HHS/United States
- 75N92019D00031/HL/NHLBI NIH HHS/United States
- R01 HL080124/HL/NHLBI NIH HHS/United States
- R01 HL142983/HL/NHLBI NIH HHS/United States
- KL2 RR031981/RR/NCRR NIH HHS/United States
- R01 HL128914/HL/NHLBI NIH HHS/United States
- R01 HL134168/HL/NHLBI NIH HHS/United States
- R01 HL131532/HL/NHLBI NIH HHS/United States
- K23 DK113252/DK/NIDDK NIH HHS/United States
- R15 HL121761/HL/NHLBI NIH HHS/United States
- R01 HL126136/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous